Main Navigation
Mercia
Ventures
Debt
Private equity
Team
Contact us
About us
Investment strategies
Investor area
PLC
EIS
VCT
Contact us
Audience
|
Change
Ventures
Debt
Private equity
Team
Contact us
About us
About us
Our history
Our vision and values
University partnerships
Team
Careers
Portfolio
Sustainability
Strategies
Our investment strategy
Our funds
Strategic assets
Property development finance
EIS & VCT
For shareholders
Share price
Board of directors
Financial reports & presentations
Regulatory news
Corporate governance
AIM Rule 26
Organisational structure
Annual Report
VCT
Northern Venture Trust
Northern 2 VCT
Northern 3 VCT
Insights & Research
Hub
Ventures
Debt
Private equity
Team
Contact us
About us
Investment strategies
Investor area
PLC
EIS
VCT
Contact us
About us
About us
Our history
Our vision and values
University partnerships
Team
Careers
Portfolio
Sustainability
Strategies
Our investment strategy
Our funds
Strategic assets
Property development finance
EIS & VCT
For shareholders
Share price
Board of directors
Financial reports & presentations
Regulatory news
Corporate governance
AIM Rule 26
Organisational structure
Annual Report
VCT
Northern Venture Trust
Northern 2 VCT
Northern 3 VCT
Insights & Research
Hub
Mercia Digital Fund launch
Mercia EIS Funds | 15th August, 2014
Mercia Digital Fund launch
Mercia EIS Funds | 30th July, 2014
Oxford Genetics secures additional funding from Mercia and TSB
Mercia EIS Funds | 21st July, 2014
Mercia Fund Management makes £229,000 investment in InoCardia
Mercia EIS Funds | 17th July, 2014
Finance Bill should boost Britain’s world-leading technology firms
Mercia EIS Funds | 11th July, 2014
Abzena float represents a profitable return for Mercia’s investors
Mercia EIS Funds | 9th July, 2014
Abzena raises £20 million in connection with forthcoming admission to AIM
Mercia EIS Funds | 18th June, 2014
Abzena intention to float
Mercia EIS Funds | 10th June, 2014
Mercia Fund Management makes £150,000 investment in Dab Gaming
Mercia EIS Funds | 6th June, 2014
Antitope and Baylor Institute for Immunology Research to Collaborate to Produce Manufacturing Cell Line for Novel Therapeutic Dendritic-cell-targeting Vaccine
Mercia EIS Funds | 4th June, 2014
Mercia Fund Management launches start-up competition
1
…
120
121
122
123
124
125
126
127
128
129
130
…
135
Loading...
Loading...
Disclaimer
Which of these options best describes you?
Please wait...
Disclaimers
Which of these options best describes you?
Please wait...
Loading...
Loading...
Disclaimer
Which of these options best describes you?
Please wait...
Disclaimers
Which of these options best describes you?
Please wait...